The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells
埃罗妥珠单抗联合来那度胺治疗的疗效取决于自然杀伤细胞、单核细胞和骨髓瘤细胞之间的相互作用。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2021.279930
Richardson, Kelden; Keam, Simon P; Zhu, Joe Jiang; Meyran, Deborah; D'Souza, Criselle; Macdonald, Sean; Campbell, Kerry; Robbins, Michael; Bezman, Natalie A; Todd, Kirsten; Quach, Hang; Ritchie, David S; Harrison, Simon J; Prince, H Miles; Trapani, Joseph A; Jenkins, Misty R; Beavis, Paul A; Darcy, Phillip K; Neeson, Paul J